Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries

Milena A Gianfrancesco¹, Kimme L Hyrich^{2

3}, Laure Gossec^{4

5}, Anja Strangfeld⁶, Loreto Carmona⁷, Elsa F Mateus^{8

9}, Paul Sufka¹⁰, Rebecca Grainger¹¹, Zachary Wallace¹², Suleman Bhana¹³, Emily Sirotich^{14

15}, Jean Liew¹⁶, Jonathan S Hausmann¹⁷, Wendy Costello¹⁸, Philip Robinson¹⁹, Pedro M Machado^{20

21

22}, Jinoos Yazdany¹; COVID-19 Global Rheumatology Alliance Steering Committee

Affiliations

¹ Division of Rheumatology, Department of Medicine, University of California San Francisco, San Francisco, 94143 CA, USA.
² Centre for Epidemiology Versus Arthritis, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
³ National Institute of Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
⁴ Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris France.
⁵ Rheumatology Department, Pitié-Salpêtrière hospital, AP-HP, Paris, France.
⁶ Epidemiology Unit, German Rheumatism Research Center (DRFZ Berlin), Berlin, Germany.
⁷ Instituto de Salud Musculoesquelética, Madrid, Madrid, Spain.
⁸ Portuguese League Against Rheumatic Diseases (LPCDR), Lisbon, Portugal.
⁹ EULAR Standing Committee of PARE (People with Arthritis Rheumatism in Europe), Zurich, Switzerland.
¹⁰ Healthpartners, St. Paul, MN, USA.
¹¹ Department of Medicine, University of Otago, Dunedin, Otago, New Zealand.
¹² Massachusetts General Hospital and Program in Rheumatology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
¹³ Crystal Run Health, Middletown, NY, USA.
¹⁴ Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.
¹⁵ Canadian Arthritis Patient Alliance, Toronto, ON, Canada.
¹⁶ Division of Rheumatology, University of Washington, Seattle, WA, USA.
¹⁷ Division of Rheumatology and Clinical Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
¹⁸ Irish Children's Arthritis Network (iCAN), Tipperary, Ireland.
¹⁹ University of Queensland Faculty of Medicine, Brisbane, QLD, Australia.
²⁰ Centre for Rheumatology and Department of Neuromuscular Diseases, University College London, London, UK.
²¹ Department of Rheumatology and Queen Square Centre for Neuromuscular Diseases, University College London Hospitals NHS Foundation Trust, London, UK.
²² Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS trust, London, UK.

PMID: 32309814
PMCID: PMC7162647
DOI: 10.1016/S2665-9913(20)30095-3

Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries

Milena A Gianfrancesco et al. Lancet Rheumatol. 2020 May.

. 2020 May;2(5):e250-e253.

doi: 10.1016/S2665-9913(20)30095-3. Epub 2020 Apr 16.

Authors

Affiliations

¹ Division of Rheumatology, Department of Medicine, University of California San Francisco, San Francisco, 94143 CA, USA.
² Centre for Epidemiology Versus Arthritis, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
³ National Institute of Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
⁴ Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris France.
⁵ Rheumatology Department, Pitié-Salpêtrière hospital, AP-HP, Paris, France.
⁶ Epidemiology Unit, German Rheumatism Research Center (DRFZ Berlin), Berlin, Germany.
⁷ Instituto de Salud Musculoesquelética, Madrid, Madrid, Spain.
⁸ Portuguese League Against Rheumatic Diseases (LPCDR), Lisbon, Portugal.
⁹ EULAR Standing Committee of PARE (People with Arthritis Rheumatism in Europe), Zurich, Switzerland.
¹⁰ Healthpartners, St. Paul, MN, USA.
¹¹ Department of Medicine, University of Otago, Dunedin, Otago, New Zealand.
¹² Massachusetts General Hospital and Program in Rheumatology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
¹³ Crystal Run Health, Middletown, NY, USA.
¹⁴ Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.
¹⁵ Canadian Arthritis Patient Alliance, Toronto, ON, Canada.
¹⁶ Division of Rheumatology, University of Washington, Seattle, WA, USA.
¹⁷ Division of Rheumatology and Clinical Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
¹⁸ Irish Children's Arthritis Network (iCAN), Tipperary, Ireland.
¹⁹ University of Queensland Faculty of Medicine, Brisbane, QLD, Australia.
²⁰ Centre for Rheumatology and Department of Neuromuscular Diseases, University College London, London, UK.
²¹ Department of Rheumatology and Queen Square Centre for Neuromuscular Diseases, University College London Hospitals NHS Foundation Trust, London, UK.
²² Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS trust, London, UK.

PMID: 32309814
PMCID: PMC7162647
DOI: 10.1016/S2665-9913(20)30095-3

No abstract available

PubMed Disclaimer

References

1. Furst DE. The risk of infections with biologic therapies for rheumatoid arthritis. Semin Arthritis Rheum. 2010;39:327–346. - PubMed
1. Kahl LE. Herpes zoster infections in systemic lupus erythematosus: risk factors and outcome. J Rheumatol. 1994;21:84–86. - PubMed
1. Kourbeti IS, Ziakas PD, Mylonakis E. Biologic therapies in rheumatoid arthritis and the risk of opportunistic infections: a meta-analysis. Clin Infect Dis. 2014;58:1649–1657. - PubMed
1. Winthrop KL. Infections and biologic therapy in rheumatoid arthritis: our changing understanding of risk and prevention. Rheum Dis Clin North Am. 2012;38:727–745. - PubMed
1. Kim AHJ, Sparks JA, Liew JW. A rush to judgment? Rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for COVID-19. Ann Intern Med. 2020 doi: 10.7326/M20-1223. published online March 30. - DOI - PMC - PubMed

Grants and funding

LinkOut - more resources

Full Text Sources
Medical
- ClinicalTrials.gov

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries

Affiliations

Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries

Authors

Affiliations

References

Grants and funding

LinkOut - more resources

Full Text Sources

Medical